Biolux Research Ltd, Vancouver, Canada, announced the appointment of Celestica HealthTech, Toronto, as its manufacturing partner for commercialization of the new OrthoPulse™ technology, which is designed to accelerate orthodontic tooth movement and reduce treatment timelines.
According to Biolux, Celestica provides knowledge, expertise, and focus to end-to-end product lifecycle solutions for customers in industry sectors, such as healthcare, computing, and communications.
“We are very pleased to work with Celestica as our manufacturing partner as we ramp-up for the commercial launch of our new OrthoPulse product,” says Kevin Strange, president and CEO of Biolux. “The Celestica team has been excellent to work with, and we are very much aligned in our attention to design and manufacturing processes, leading to a top-quality solution for orthodontic patients. In addition, the scalability of Celestica will ensure that they can handle planned volumes of our revolutionary product for accelerating orthodontic treatment.”